申请人:Astra Lakemedel Aktiebolag
公开号:US03976771A1
公开(公告)日:1976-08-24
A novel class of glycylglycine amides has been discovered having value as antiarrhythmic agents. The preferred compound of the present invention has the structural formula ##EQU1## Also included within the scope of this invention are compounds having C.sub.1 -C.sub.3 alkyl, alkoxy and halo substituents in the ortho, para or meta positions of the aromatic ring, compounds in which the phenyl group is replaced by benzyl or substituted benzyl and compounds in which the glycylglycine chain may be substituted with lower alkyl groups or may contain heterocyclic rings.
一种新型的甘氨酸酰胺类化合物被发现具有抗心律失常药物的价值。本发明的首选化合物具有下列结构式:##EQU1## 本发明的范围还包括具有C.sub.1-C.sub.3烷基、烷氧基和卤素取代基的芳环的邻、对或间位,以苯基被苄基或取代苄基所替代的化合物,以及甘氨酸甘氨酰链可能被低烷基取代或含有杂环的化合物。